Not a member? Sign Up

Reasons for Joining

    Address your challenges through knowledge sharing with peers from our global network of specialists.

    Benchmark your business initiatives with the who's who in the field.

    Hear from industry pioneers how to maximize ROI in today's challenging economy.

    And best of all It's FREE!
Sign in using your existing
Pharma IQ account
Username or Email:

Sign Up  |  Already a member? Sign In  |  Visit IQPC.com  
Pharma IQ


hESC derived Cytiva™ Cardiomyocytes for Drug Safety Testing

 This FREE webinar was recorded on:
Wednesday, March 28, 2012,
10:00 AM - 11:00 AM ET

Register


Learn how to sponsor a webinar with us?

Tags: drug safety testing | Cytiva Cardiomyocytes | cardiac drug liabilities | toxicity | high-content assays | cardiotoxicity | hESC derived cardiomyocytes | hESC | Nick Thomas | GE | Human embryonic stem cell-derived | cell model | clinically predictive cardiotoxicity assays



This presentation demonstrates how hESC derived cardiomyocytes can be a powerful approach to assessing cardiac drug liabilities. Nick Thomas describes how hESC derived Cytiva Cardiomyocytes:

  • are a valid model of cardiomyocytes from the human heart
  • are compatible with assays routinely used for testing cardiotoxicity
  • together with high-content assays and analysis, can indicate the mechanism of toxicity of drug compounds


Presenter:

Nick Thomas PhD
Nick Thomas PhD
Principal Scientist
Cell Technologies

Dr. Nick Thomas is Principal Scientist at GE Healthcare Life Sciences. In a twenty-seven year career he is the inventor or co-inventor of over 60 patents covering a wide range of technologies from microfabrication to molecular and cellular sensors.



To view this FREE Webinar register here.
Already a member of Pharma IQ? Sign in to register.

First Name:  *
Last Name:  *
Job Title:  *
E-mail:  *
Phone:  *
Company:  *
Country:
User Name:  *
Password:  *
Confirm Password:  *
Which of the following best describes your area of expertise?


Please answer the following questions:
By ticking this box you confirm that you have read and agree to the sponsor's Privacy Policy
Yes
Please select which specific types of email you would like to receive
Receive quarterly e-newsletters by email
Receive emails about upcoming webinars and events
Receive emails about new and existing products

Profile Information
I would like to receive promotional emails from GE Healthcare Life Sciences Privacy Policy
Receive quarterly e-newsletters by email
Receive emails about upcoming webinars and events
Receive emails about new and existing products
Be the first to leave a comment
Sign in or Sign up to post a comment
Advertisement

Recent Activity

* = required.

Not a member yet? Sign up
User Name:
Password: